From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Accrol Group – half-year results claim “remains well placed”. Hmmm…

By Steve Moore | Tuesday 23 January 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Accrol Group (ACRL) has announced results for its half year ended 31st October 2017 including “revenue increased by 13.1% to £72.3m” and “the group remains well placed to benefit from its strong position as a major UK supplier of non-discretionary tissue products into the consumer value sector… Growth in these sectors is being driven primarily by increasing Private Label product sales, which continue to take market share from well-known brands”. Sounds promising…


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 21:11:53